Aldeyra Therapeutics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for ALDX, updated each market day.
ALDX AI Sentiment
AI predicts Aldeyra Therapeutics, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Sector
Exchange
Market Cap
$95,690,623
Cap Tier
Employees
8
Headquarters
LEXINGTON, MA
Listed Since
May 2, 2014
Website
ALDX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ALDX Volatility
Aldeyra Therapeutics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
